Gliclazide reduces oxidative stress, blocks PI3K signal transmission, and reduces matrix metalloproteinase 2 (MMP-2), cathepsin K, and RANKL levels in the rat periodontitis model. The gene discussed is MMP2; the disease is periodontitis.